Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sumatriptan for post-ECT headache

R M Fantz1, J S Markowitz, C H Kellner

  • 1Institute of Psychiatry, Medical University of South Carolina, Charleston 29425, USA.

The Journal of ECT
|January 1, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When to consider electroconvulsive therapy (ECT).

Acta psychiatrica Scandinavica·2019
Same author

'Treatment resistance' in electroconvulsive therapy (ECT) patients: time to move on.

Acta psychiatrica Scandinavica·2019
Same author

Reliable, fast antidepressant treatment: restating the case for electroconvulsive therapy.

Acta psychiatrica Scandinavica·2019
Same author

Electroconvulsive therapy in unipolar depression treatment guidelines.

Acta psychiatrica Scandinavica·2018
Same author

A systematic review of left unilateral electroconvulsive therapy.

Acta psychiatrica Scandinavica·2017
Same author

The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis.

Acta psychiatrica Scandinavica·2017
Same journal

Successful Use of Electroconvulsive Therapy in Treatment-Resistant Catatonia With Comorbid Parkinson Disease and Neuroborreliosis: A Case Report.

The journal of ECT·2026
Same journal

Electroconvulsive Therapy in Movement Disorders: A Systematic Review.

The journal of ECT·2026
Same journal

Presyncope During Repetitive Transcranial Magnetic Stimulation With Treatment Continuation.

The journal of ECT·2026
Same journal

Comparison of Electroconvulsive Therapy Seizure Outcomes When Using Methohexital Versus Propofol: A Brief Retrospective Report.

The journal of ECT·2026
Same journal

Changes in the Use of Repetitive Transcranial Magnetic Stimulation Therapy Between 2016 and 2022 in Northern Finland.

The journal of ECT·2026
Same journal

Evaluation of Cardiac Adverse Effects After Transition From Bitemporal to Bifrontal ECT.

The journal of ECT·2026
See all related articles

Post-electroconvulsive therapy (ECT) headaches in a patient with depression were refractory to standard pain relievers. Oral sumatriptan effectively treated these headaches, suggesting its potential use for similar refractory cases.

Area of Science:

  • Neurology
  • Psychiatry
  • Pharmacology

Background:

  • Electroconvulsive therapy (ECT) is a treatment for severe depression.
  • Headaches are a common side effect following ECT.
  • Conventional analgesics like acetaminophen and NSAIDs are often used for post-ECT headaches.

Observation:

  • A 27-year-old woman experienced severe headaches after ECT that did not respond to acetaminophen or NSAIDs.
  • The patient's refractory headaches were successfully managed with oral sumatriptan.

Findings:

  • Sumatriptan demonstrated efficacy in treating post-ECT headaches resistant to standard treatments.
  • This case highlights a potential therapeutic option for refractory post-ECT headache.

Implications:

Related Experiment Videos

  • Sumatriptan may be a valuable alternative for managing difficult-to-treat headaches after ECT.
  • Further research could explore the role of triptans in managing post-ECT side effects.
  • This finding could improve patient comfort and adherence to ECT treatment.